Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Co-Packing Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Co-Packing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Co-Packing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Co-Packing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Co-Packing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Co-Packing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Co-Packing market include Unicep Packaging, TricorBraun, Sharp Packaging Services, Ropack Pharma Solutions, Reed-Lane, Precision Medical Products, Inc., Pharma Packaging Solutions, PCI Pharma Services and Jones Packaging Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Co-Packing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Co-Packing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Co-Packing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Co-Packing market.
Pharmaceutical Co-Packing Segment by Company
Unicep Packaging
TricorBraun
Sharp Packaging Services
Ropack Pharma Solutions
Reed-Lane
Precision Medical Products, Inc.
Pharma Packaging Solutions
PCI Pharma Services
Jones Packaging Inc.
CCL Industries
Cardinal Health
Berlin Packaging
Baxter BioPharma Solutions
Pharmaceutical Co-Packing Segment by Type
Glass Containers
Plastic Bottles
Blister Packs
Others
Pharmaceutical Co-Packing Segment by Application
OTC Pharmaceutical Companies
RX Pharmaceutical Companies
Others
Pharmaceutical Co-Packing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Pharmaceutical Co-Packing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Co-Packing key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Co-Packing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Co-Packing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Co-Packing significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Co-Packing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Co-Packing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Co-Packing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Co-Packing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Co-Packing industry.
Chapter 3: Detailed analysis of Pharmaceutical Co-Packing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Co-Packing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Co-Packing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Glass Containers
- Plastic Bottles
- Blister Packs
- Others
Applications
- OTC Pharmaceutical Companies
- RX Pharmaceutical Companies
- Others
Companies covered
- Unicep Packaging
- TricorBraun
- Sharp Packaging Services
- Ropack Pharma Solutions
- Reed-Lane
- Precision Medical Products, Inc.
- Pharma Packaging Solutions
- PCI Pharma Services
- Jones Packaging Inc.
- CCL Industries
- Cardinal Health
- Berlin Packaging
- Baxter BioPharma Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Co-Packing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Co-Packing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Co-Packing Market Dynamics
- 2.1 Pharmaceutical Co-Packing Industry Trends
- 2.2 Pharmaceutical Co-Packing Industry Drivers
- 2.3 Pharmaceutical Co-Packing Industry Opportunities and Challenges
- 2.4 Pharmaceutical Co-Packing Industry Restraints
3 Pharmaceutical Co-Packing Market by Company
- 3.1 Global Pharmaceutical Co-Packing Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Co-Packing Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Co-Packing Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Co-Packing Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Co-Packing Company Product Type and Application
- 3.6 Global Pharmaceutical Co-Packing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Co-Packing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Co-Packing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Co-Packing Market by Type
- 4.1 Pharmaceutical Co-Packing Type Introduction
- 4.1.1 Glass Containers
- 4.1.2 Plastic Bottles
- 4.1.3 Blister Packs
- 4.1.4 Others
- 4.2 Global Pharmaceutical Co-Packing Sales Value by Type
- 4.2.1 Global Pharmaceutical Co-Packing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Co-Packing Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Co-Packing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Co-Packing Market by Application
- 5.1 Pharmaceutical Co-Packing Application Introduction
- 5.1.1 OTC Pharmaceutical Companies
- 5.1.2 RX Pharmaceutical Companies
- 5.1.3 Others
- 5.2 Global Pharmaceutical Co-Packing Sales Value by Application
- 5.2.1 Global Pharmaceutical Co-Packing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Co-Packing Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Co-Packing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Co-Packing Regional Value Analysis
- 6.1 Global Pharmaceutical Co-Packing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Co-Packing Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Co-Packing Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Co-Packing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Co-Packing Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Co-Packing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Co-Packing Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Co-Packing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Co-Packing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Co-Packing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Co-Packing Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Co-Packing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Co-Packing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Co-Packing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Co-Packing Country-level Value Analysis
- 7.1 Global Pharmaceutical Co-Packing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Co-Packing Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Co-Packing Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Co-Packing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Co-Packing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Co-Packing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Co-Packing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Unicep Packaging
- 8.1.1 Unicep Packaging Company Information
- 8.1.2 Unicep Packaging Business Overview
- 8.1.3 Unicep Packaging Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.1.4 Unicep Packaging Pharmaceutical Co-Packing Product Portfolio
- 8.1.5 Unicep Packaging Recent Developments
- 8.2 TricorBraun
- 8.2.1 TricorBraun Company Information
- 8.2.2 TricorBraun Business Overview
- 8.2.3 TricorBraun Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.2.4 TricorBraun Pharmaceutical Co-Packing Product Portfolio
- 8.2.5 TricorBraun Recent Developments
- 8.3 Sharp Packaging Services
- 8.3.1 Sharp Packaging Services Company Information
- 8.3.2 Sharp Packaging Services Business Overview
- 8.3.3 Sharp Packaging Services Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.3.4 Sharp Packaging Services Pharmaceutical Co-Packing Product Portfolio
- 8.3.5 Sharp Packaging Services Recent Developments
- 8.4 Ropack Pharma Solutions
- 8.4.1 Ropack Pharma Solutions Company Information
- 8.4.2 Ropack Pharma Solutions Business Overview
- 8.4.3 Ropack Pharma Solutions Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.4.4 Ropack Pharma Solutions Pharmaceutical Co-Packing Product Portfolio
- 8.4.5 Ropack Pharma Solutions Recent Developments
- 8.5 Reed-Lane
- 8.5.1 Reed-Lane Company Information
- 8.5.2 Reed-Lane Business Overview
- 8.5.3 Reed-Lane Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.5.4 Reed-Lane Pharmaceutical Co-Packing Product Portfolio
- 8.5.5 Reed-Lane Recent Developments
- 8.6 Precision Medical Products, Inc.
- 8.6.1 Precision Medical Products, Inc. Company Information
- 8.6.2 Precision Medical Products, Inc. Business Overview
- 8.6.3 Precision Medical Products, Inc. Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.6.4 Precision Medical Products, Inc. Pharmaceutical Co-Packing Product Portfolio
- 8.6.5 Precision Medical Products, Inc. Recent Developments
- 8.7 Pharma Packaging Solutions
- 8.7.1 Pharma Packaging Solutions Company Information
- 8.7.2 Pharma Packaging Solutions Business Overview
- 8.7.3 Pharma Packaging Solutions Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.7.4 Pharma Packaging Solutions Pharmaceutical Co-Packing Product Portfolio
- 8.7.5 Pharma Packaging Solutions Recent Developments
- 8.8 PCI Pharma Services
- 8.8.1 PCI Pharma Services Company Information
- 8.8.2 PCI Pharma Services Business Overview
- 8.8.3 PCI Pharma Services Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.8.4 PCI Pharma Services Pharmaceutical Co-Packing Product Portfolio
- 8.8.5 PCI Pharma Services Recent Developments
- 8.9 Jones Packaging Inc.
- 8.9.1 Jones Packaging Inc. Company Information
- 8.9.2 Jones Packaging Inc. Business Overview
- 8.9.3 Jones Packaging Inc. Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.9.4 Jones Packaging Inc. Pharmaceutical Co-Packing Product Portfolio
- 8.9.5 Jones Packaging Inc. Recent Developments
- 8.10 CCL Industries
- 8.10.1 CCL Industries Company Information
- 8.10.2 CCL Industries Business Overview
- 8.10.3 CCL Industries Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.10.4 CCL Industries Pharmaceutical Co-Packing Product Portfolio
- 8.10.5 CCL Industries Recent Developments
- 8.11 Cardinal Health
- 8.11.1 Cardinal Health Company Information
- 8.11.2 Cardinal Health Business Overview
- 8.11.3 Cardinal Health Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.11.4 Cardinal Health Pharmaceutical Co-Packing Product Portfolio
- 8.11.5 Cardinal Health Recent Developments
- 8.12 Berlin Packaging
- 8.12.1 Berlin Packaging Company Information
- 8.12.2 Berlin Packaging Business Overview
- 8.12.3 Berlin Packaging Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.12.4 Berlin Packaging Pharmaceutical Co-Packing Product Portfolio
- 8.12.5 Berlin Packaging Recent Developments
- 8.13 Baxter BioPharma Solutions
- 8.13.1 Baxter BioPharma Solutions Company Information
- 8.13.2 Baxter BioPharma Solutions Business Overview
- 8.13.3 Baxter BioPharma Solutions Pharmaceutical Co-Packing Revenue and Gross Margin (2021-2026)
- 8.13.4 Baxter BioPharma Solutions Pharmaceutical Co-Packing Product Portfolio
- 8.13.5 Baxter BioPharma Solutions Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst